Source: BIOPORTFOLIO

Enzymatics: QIAGEN Acquires Enzymatics Enzyme Solutions Unit a Leading Enabler of NGS Applications

HILDEN Germany and BEVERLY Massachusetts January 11 2015 PRNewswire &160;Enzymatics products used in 80 of all global NGS sequencing reactions&160;Strengthens QIAGEN's universal NGS product offering and strategy to offer complete NGS workflows from...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more